Penwood
GhostPenwood is an essay newsletter by a commercial leader who advises biopharma and MedTech companies on launch strategy and AI adoption. Each issue argues a specific point, such as why launches miss forecasts, why commercial teams stall on AI, or why connected-device data decisions belong before regulatory clearance, backed by industry studies and the author's experience at Novartis and Sanofi.